IVB-103

N/A

Report date: 2025/02/14 15:13:58

Base Information

Drug NameIVB-103
Drug Alias NameIVB-103
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsWet age-related macular degenerationMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Yinnuo Weikang Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Nuowei Biomedical Technology Co LtdBeijing Yinnuo Weikang Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsWet age-related macular degenerationMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A